Literature DB >> 33608626

Predictors of pharmacologic therapy for neonatal opioid withdrawal syndrome: a retrospective analysis of a statewide database.

Rachana Singh1, Mary Houghton2, Patrice Melvin3, Elisha M Wachman4, Hafsatou Diop5, Ronald Iverson4, Alan Picarillo6, Lawrence Rhein7, Munish Gupta2.   

Abstract

OBJECTIVE: Identify factors associated with the need for pharmacologic therapy (PT) among opioid exposed newborn (OENs). STUDY
DESIGN: Retrospective analysis of a statewide database of OENs from 2017 through 2019. Multivariable mixed-effects logistic regression modeled the association of maternal characteristics, infant characteristics, and family engagement practices on the receipt of PT.
RESULTS: Of 2098 OENs, 44.8% required PT for NOWS. Higher odds of PT were associated with in-utero exposure to medication treatment for opioid use disorder (MOUD) and non-prescribed opioids in addition to MOUD; nicotine, benzodiazepines, SSRIs; male; out-born infants and mother's ineligibility to provide breast-milk. Lower odds were associated with increasing birth year, skin-to-skin (STS) care, and rooming-in.
CONCLUSION: Male, out-born infants exposed to MOUD with additional non-prescribed opioids, nicotine, benzodiazepines and SSSRIs with mothers ineligible to provide breast-milk were more likely to require PT, while modifiable care practices including STS care, and rooming-in decreased the likelihood of PT.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33608626     DOI: 10.1038/s41372-021-00969-z

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   3.225


  3 in total

1.  The combined effects of alcohol and tobacco use during pregnancy on birth outcomes

Authors:  Jadwiga Hamułka; Monika A. Zielińska; Katarzyna Chądzyńska
Journal:  Rocz Panstw Zakl Hig       Date:  2018

2.  Impact of Parental Presence at Infants' Bedside on Neonatal Abstinence Syndrome.

Authors:  Mary Beth Howard; Davida M Schiff; Nicole Penwill; Wendy Si; Anjali Rai; Tahlia Wolfgang; James M Moses; Elisha M Wachman
Journal:  Hosp Pediatr       Date:  2017-02

3.  Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?

Authors:  Alane B O'Connor; Liam O'Brien; William A Alto
Journal:  J Perinat Med       Date:  2013-09-01       Impact factor: 1.901

  3 in total
  1 in total

1.  Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome.

Authors:  Shawana Bibi; Nathan Gaddis; Eric O Johnson; Barry M Lester; Walter Kraft; Rachana Singh; Norma Terrin; Susan Adeniyi-Jones; Jonathan M Davis
Journal:  Pediatr Res       Date:  2022-08-16       Impact factor: 3.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.